Chronic inflammation and impaired immune tolerance are hallmarks of inflammatory bowel disease. Here, the authors report on Treg and platelet fused exosomes for targeted delivery of attached MMP cleavable IL-23 antibodies for immune modulation to prevent IBD progression.
